Neuroblasztóma: vizsgálatok itt: Spanyolország
10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 12.. Ask the study team whether a trial fits you.
- 2. fázisTaking people177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
- Where
- Esplugues de Llobregat
- Életkor
- 18 hónap to 64 év
- People
- 24 worldwide
- Run by
- Jakob Stenman
See details and how to joinNCT04903899 · EU 2023-503684-42-00 - 2/3. fázisTaking peopleA Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
- Where
- Barcelona, Madrid
- Életkor
- 18 hónap to 18 év
- People
- 144 worldwide
- Run by
- Renaissance Pharma Ltd.
See details and how to joinNCT07549321 · EU 2025-524397-42-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Barcelona, Esplugues De Llobregat, Madrid, Valencia
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 2. fázisTaking peopleNaxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Where
- Esplugues de Llobregat
- Életkor
- 12 hónap to 21 év
- People
- 93 worldwide
- Run by
- Giselle Sholler
See details and how to joinNCT05489887 · EU 2025-524140-35-00 - 1/2. fázisTaking peopleStudy in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).
- Where
- Boadilla del Monte
- Életkor
- 3 év and over
- People
- 25
- Run by
- Fundación de investigación HM
See details and how to joinNCT06607692 · EU 2024-512613-40-00 - 1/2. fázisTaking peopleA phase 1B of crizotinib either in combination or as single agent in pediatric patients with ALK, ROS1 or MET positive malignancies
- Where
- Barcelona, Madrid, Sevilla, Valencia
- Életkor
- Up to 64 év
- People
- 72 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504880-18-00 · EU 2023-504880-18-00 - 1/2. fázisTaking peopleA phase I/II trial of ABTL0812 in children with relapsed/refractory neuroblastoma and other solid tumours
- Where
- Barakaldo, Barcelona, Esplugues De Llobregat, Madrid, Sevilla, Valencia
- Életkor
- Up to 64 év
- People
- 48
- Run by
- Fir Huvh Fundacio Institut De Recerca Hospital Universitari Vall De Hebron
See details and how to join2023-504246-64-02 · EU 2023-504246-64-02 - 1/2. fázisTaking peopleA Multi-Arm, Platform Trial For Relapsed Neuroblastoma
- Where
- Barakaldo, Barcelona, Madrid, Sevilla, Valencia
- Életkor
- 1 év to 64 év
- People
- 160 worldwide
- Run by
- University of Birmingham
See details and how to joinNCT07334301 · EU 2024-516115-24-00 - 1. fázisTaking peopleStudy Combining Dinutuximab Beta With Two Chemotherapy Regimens in Neuroblastoma
- Where
- Barcelona, Valencia
- Életkor
- 18 hónap to 18 év
- People
- 38 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT06485947 · EU 2023-509673-22-00 - 3. fázisTaking peopleHigh-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
- Where
- Barakaldo, Barcelona, Donostia, El Palmar, Murcia, Madrid, Malaga, Palma, Santiago de Compostela, Sevilla, Valencia
- Életkor
- Up to 21 év
- People
- 800 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT04221035 · EU 2024-514917-36-00